Filing Details
- Accession Number:
- 0001209191-20-027901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 16:24:51
- Reporting Period:
- 2020-05-07
- Accepted Time:
- 2020-05-08 16:24:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197036 | I Bruce Sachs | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-07 | 22,500 | $59.55 | 33,710 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-07 | 22,500 | $81.54 | 56,210 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-07 | 2,600 | $267.50 | 53,610 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 11,568 | $268.65 | 42,042 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 15,751 | $269.53 | 26,291 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 5,889 | $270.49 | 20,402 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 6,232 | $271.63 | 14,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-07 | 2,960 | $272.46 | 11,210 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-07 | 22,500 | $0.00 | 22,500 | $59.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-07 | 22,500 | $0.00 | 22,500 | $81.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-05-31 | No | 4 | M | Direct | |
| 0 | 2023-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $267.50 (range $267.06 to $268.03).
- Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $268.65 (range $268.06 to $269.03).
- Open market sales reported on this line occurred at a weighted average price of $269.53 (range $269.06 to $270.04).
- Open market sales reported on this line occurred at a weighted average price of $270.49 (range $270.09 to $271.08).
- Open market sales reported on this line occurred at a weighted average price of $271.63 (range $271.17 to $272.14).
- Open market sales reported on this line occurred at a weighted average price of $272.46 (range $272.21 to $272.94).
- Fully vested.
Billionaire Hedge Funds
